TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
--- --- --- --- --- --- --- ---

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
Diluted P/E:
RSI(14) 1m:
51.72
VWAP:
0.42
RVol:
0.0129

Events

Period Kind Movement Occurred At

Related News